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Co-infections with HCV and HIV are common, because
both viruses share routes of transmission and establish
chronic infections. The standard treatment for chronic
hepatitis C, a combination of peginterferon-a and riba-
virin, is poorly tolerated and only successful in about
half of the treated patients. Thus, identification of accu-
rate predictors of treatment response is highly desirable.
Several independent genome-wide association studies
have recently identified human genetic variants around
the IL28B gene (coding for IFN-l3) that strongly associ-
ate with spontaneous clearance of HCV and with treat-
ment success, both in HCV mono-infected and in co-
infected patients. I will put these findings in perspective
and discuss their practical and theoretical implications
with regard to drug development, clinical trial design
and clinical management of chronic HCV infection.
Results of detailed genetic and functional analyses of the
IL28B gene region will also be presented.
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